Advertisement
CervoMed Inc.

CervoMed Inc. (CRVO) Stock Overview

Explore CervoMed Inc.’s financial performance, market position, analyst ratings, and future outlook.

CRVONASDAQ
HealthcareBiotechnology
$4.52
$2.04(82.26%)
U.S. Market opens in 8h 9m
Advertisement

CervoMed Inc. (CRVO)

Meyka AI Score

Z

Key Financials

Market Cap41.8M
P/E Ratio-1.46
EPS (TTM)$-3.28
ROE-1.36%
Fundamental Analysis

AI Price Forecasts

1 Month$12.62
3 Months$14.64
1 Year Target$4.28

CRVO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CervoMed Inc. (CRVO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.53, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $4.28.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.46 and a market capitalization of 41.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
82.26%
5-Day Change
95.67%
1-Month Change
31.40%
3-Month Change
4.87%
6-Month Change
-45.87%
Year-to-Date (YTD) Change
-42.78%
1-Year Change
-37.74%
3-Year Change
-19.86%
5-Year Change
-91.74%
All-Time (Max) Change
-100.00%

Contact Information

617-744-4400
20 Park Plaza, Boston, MA, 02116

Company Facts

150 Employees
IPO DateMay 23, 2008
CountryUS
Actively Trading

Frequently Asked Questions